Cannabis-related hospitalizations: Unexpected serious events identified through hospital databases

British Journal of Clinical Pharmacology

Volumn 71, Issue 5, 2011, Pages 758-765

  Jouanjus, Emilie ^a   Leymarie, Florence ^b   Tubery, Marie ^b   Lapeyre Mestre, Maryse ^a,b  

^a Faculté de Médecine Centre Hospitalo universitaire   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Adverse event; Cannabis; Hospitalization; Pharmacoepidemiology

Indexed keywords

CANNABIS; ILLICIT DRUG;

ADULT; ARTICLE; CANNABIS ADDICTION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DATA BASE; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; INCIDENCE; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PUBLIC HOSPITAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT;

EID: 79953880214     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03897.x     Document Type: Article

References (30)

1. United Nations Office of Drugs and Crime (UNODC). World drug report 2009. United Nations publications, 314 p. Available at (last accessed 6 August 2010).
2. Beck F, Legleye S, Spilka S. Niveaux d'usage et profils des usagers en France en 2005. In: Costes JM, Cannabis, Données Essentielles, eds. Martineau H, Ades JE. Saint-Denis: Observatoire français des drogues et toxicomanies (OFDT), 2007; 20-9. Available at (last accessed 6 August 2010).
3. Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010; 340: c1571.Review.
4. [No authors listed]. Cannabis and the cardiovascular system. Br Med J 1978; 1: 460-1.
5. Sterne J, Ducastaing C. [Arteritis caused by Cannabis indica]. Arch Mal Coeur Vaiss 1960; 53: 143-7. French.
6. Mohan H, Sood GC. Conjugate deviation of the eyes after Cannabis indica intoxication. Br J Ophthalmol 1964; 48: 160-1.
7. Charles R, Holt S, Kirkham N. Myocardial infarction and marijuana. Clin Toxicol 1979; 14: 433-8.
8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH topic E6 (R1): Guideline for good clinical practice (CPMP/ICH/135/95). London: European Medecines Agency, 1996.
9. Institut National de la Statistique et des Etudes Economiques (INSEE). 2009 [Internet]. Statistiques locales, chiffres clés sur un territoire [updated 01/12/2009]. INSEE. Available at (last accessed 6 August 2010).
10. World Health Organization [Internet]. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007; c1994/2006 [update 05/04/2006]. World Health Organization. Available at: (last accessed 6 August 2010).
11. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-9.
12. Wiholm BE, Olsson S, Moore N, Waller P. Spontaneous reporting systems outside the US. In: Pharmacoepidemiology, ed. Strom BL. 3rd edn. Chichester: Wiley, 2000; 175-92.
13. WHO. International Monitoring of Adverse Reactions to Drugs: Adverse Reaction Terminology. Uppsala: WHO Collaborating Centre for International Drug Monitoring, 1992.
14. Beck F, Legleye S, Spilka S. Cannabis, cocaïne, ecstasy: entre expérimentation et usage régulier. In: Baromètre santé 2005. Attitudes et comportement de santé, ed. Cormand MF. Saint-Denis: Institut national de prévention et d'éducation pour la santé (INPES), Baromètres santé, 2007; 169-221. Available at (last accessed 6 August 2010).
15. Institut National de la Statistique et des Etudes Economiques (INSEE). 2008 [Internet]. Estimation de population par sexe et âge quinquennal, Années 1990-2007 [updated 05/2008]. INSEE. Available at: (last accessed 6 August 2010).
16. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009; 374: 1383-91.
17. Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol 2007; 118: 141-4.
18. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med 1974; 291: 65-7.
19. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001; 103: 2805-9.
20. Combemale P, Consort T, Denis-Thelis L, Estival JL, Dupin M, Kanitakis J. Cannabis arteritis. Br J Dermatol 2005; 152: 166-9.
21. Bonnaud I, Giraudeau B, Julie V, Soulat L, Beaufils JM, Brock T, Goralski M, Perrotin D, les médecins référents membres du GEUC. [Epidemiology and management of stroke patients in emergency departments of the Centre region of France]. Rev Neurol 2005; 161: 311-7. French.
22. Ducasse A. (Dir), Rapport annuel sur l'activité des structures d'urgence en Midi-Pyrénées 2008, Observatoire Régional des Urgences Midi-Pyrénées (ORU-MIP). 2009: 169p. Available at (last accessed 6 August 2010).
23. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007; 167: 221-8.
24. Gilbert O, Mathieu D, Hanquet O, Lardinois I, Cornut P, Pierard P, Van Meerhaeghe A. [Hemoptysis in a young man]. Rev Mal Respir 2006; 23: 471-6.
25. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178: 101-6.
26. Park B, McPartland JM, Glass M. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 189-97.
27. Steinberger EK, Ferencz C, Loffredo CA. Infants with single ventricle: a population-based epidemiological study. Teratology 2002; 65: 106-15.
28. Delourme J, Delattre C, Godard P, Steenhouwer F, Just N. [Respiratory consequences of inhalation of adulterated cannabis]. Rev Mal Respir 2009; 26: 552-6. French.
29. van der Hooft CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BH. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf 2006; 29: 161-8.
30. Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007; 7: 9.